NCT04310423View on ClinicalTrials.gov

An Inflammatory Challenge Using Endotoxin

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 19, 2021

Primary Completion Date

November 14, 2023

Study Completion Date

November 14, 2023

Conditions
Alcohol Use DisorderInflammatory ResponseCravingDepressed Mood
Interventions
DRUG

Placebo

Matched to endotoxin

BIOLOGICAL

Endotoxin

Bolus dose of 0.8 ng/kg

Trial Locations (1)

90095

UCLA Addictions Laboratory, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT04310423 - An Inflammatory Challenge Using Endotoxin | Biotech Hunter | Biotech Hunter